Duration | OR | I2 (%) | Number of participants | Number of events in bleed group/total | Number of events in non-bleed group/total |
---|---|---|---|---|---|
Adjusted risk of mortality | |||||
30 days8 14 24 28 32 36 38 39 40 41 45 | 3.24 (2.73 to 3.84) | 81 | 403 457 | 3307/59 630 | 7645/317 375 |
6 months24 27 36 42 | 3.23 (2.92 to 3.57) | 0 | 50 872 | 154/1028 | 1119/20 606 |
1 year2 22 23 25 44 48 53 56 | 3.64 (2.39 to 5.56) | 89 | 74 637 | 160/2494 | 677/36 167 |
Adjusted risk of MACEs | |||||
<1 year24 34 36 | 3.96 (3.26 to 4.81) | 53 | 47 422 | 175/790 | 1204/20 180 |
>1 year43 | 3.19 (1.89 to 5.38) | NA | 3170 | NA | NA |
MACEs, major adverse cardiovascular events; NA, not applicable.